FRA10AC1 Activators
FRA10AC1 Activators encompass a range of chemical compounds that indirectly boost the functional activity of FRA10AC1 through diverse signaling mechanisms. Compounds such as Forskolin, IBMX, Rolipram, 8-Br-cAMP, Isoproterenol, and BAY 60-6583 predominantly act by elevating intracellular cAMP, subsequently activating protein kinase A (PKA). The activation of PKA is believed to enhance FRA10AC1's role in gene regulation by potentially facilitating the phosphorylation of proteins that modulate gene expression in concert with FRA10AC1. Prostaglandin E2 (PGE2) similarly contributes to the activation of FRA10AC1 through Gs-protein-coupled receptor signaling, leading to increased cAMP and PKA-mediated signaling pathways. Anisomycin acts as a JNK activator and could indirectly upregulate FRA10AC1 activity by activating transcription factors that bind to gene regions regulated by FRA10AC1, while SP600125, a JNK inhibitor, might trigger compensatory pathways that enhance FRA10AC1 function, suggesting complex interplays in cellular responses.
On the other hand, Y-27632, D4476, and SB431542 act on distinct signaling cascades that can modulate the transcriptional regulatory landscape where FRA10AC1 exerts its function. Y-27632, by inhibiting ROCK, may influence actin cytoskeleton dynamics, potentially affecting the cellular context that FRA10AC1 operates within, thereby altering its regulatory activities. D4476, a casein kinase 1 inhibitor, may lead to an accumulation of beta-catenin and subsequent activation of Wnt signaling, potentially enhancing the regulation of gene expression by FRA10AC1 by modifying the cellular transcriptional program. Furthermore, the TGF-beta receptor ALK5 inhibitor, SB431542, could result in changes in SMAD signaling, thereby indirectly promoting FRA10AC1 activity by influencing the gene expression profiles under its control. Collectively, these activators work through nuanced and interconnected pathways, culminating in the enhanced activity of FRA10AC1, which is central to its role in the regulation of gene expression without necessitating upregulation of its expression or direct activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can activate PKA. PKA phosphorylation can enhance the activity of FRA10AC1 by modulating its function as a regulator of gene expression. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to an increase in cAMP levels which indirectly may enhance the activity of FRA10AC1 through the cAMP/PKA signaling cascade. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase-4 inhibitor, increasing cAMP levels in the cell. The elevated cAMP activates PKA, which could then phosphorylate substrates to indirectly activate FRA10AC1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation leads to possible phosphorylation of proteins that may interact with FRA10AC1, indirectly enhancing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP production, leading to the activation of PKA. PKA may phosphorylate proteins that interact with FRA10AC1, potentially increasing its activity. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-6583 is an adenosine A2B receptor agonist, which increases intracellular cAMP levels, potentially enhancing FRA10AC1 activity through PKA activation and subsequent phosphorylation events. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) can activate Gs-coupled receptors, leading to cAMP accumulation and PKA activation. This indirectly may enhance FRA10AC1 activity through PKA-mediated signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator, which could lead to the activation of transcription factors that interact with the regulatory regions of genes controlled by FRA10AC1, indirectly enhancing its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which may result in compensatory cellular responses that enhance the activity of FRA10AC1 through alternative signaling pathways that are not directly inhibited. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can modulate actin cytoskeleton dynamics, potentially affecting the transcriptional regulation activity of FRA10AC1 by altering the cellular context in which it operates. | ||||||